IP Library Granted Patent US 9,845,300
Granted Patent B2
US 9,845,300 · App. 15/435,964 · Granted Dec 19, 2017

Process for preparing substituted 5-fluoro-1H-pyrazolopyridines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,845,300
App. No.
15/435,964
Granted
Dec 19, 2017
Kind
B2
Abstract

The present application relates to a novel and efficient process for preparing novel substituted 5-fluoro-1H-pyrazolopyridines of the formula (VI) which are suitable as an intermediate for production of medicaments and for production of medicaments for treatment and/or prophylaxis of cardiovascular disorders. More particularly, the 5-fluoro-1H-pyrazolopyridines of the formula (VI) are suitable for preparation of the compound of the formula (I) which serves for production of medicaments, for production of medicaments for treatment and/or prophylaxis of cardiovascular disorders.

Claims (11)

1. A process for preparing an aldehyde of formula (III)

in which R 1 and R 2 are each independently methyl, ethyl, isopropyl, phenyl or, together with the nitrogen atom to which they are bonded, are

comprising reacting trifluoromethanesulphonic anhydride with 2,2,3,3-tetrafluoro-1-propanol, without solvent, and

reacting the resulting 2,2,3,3-tetrafluoropropyl trifluoromethanesulphonate with a compound of formula (XIIa)

in which R 1 and R 2 are each as defined above to give a compound of formula (XIIIa)

in which R 1 and R 2 are each as defined above

and reacting the compound of formula (XIIIa) with methyl methanesulphonate to give a compound of the formula (XIVa)

in which R 1 and R 2 are each as defined above

and reacting the compound of (XIVa) with sodium hydroxide to give a compound of formula (XVa)

in which R 1 and R 2 are each as defined above

and reacting the compound of formula (XVa) with a compound of the formula (XIIa) to give the compound of formula (III).

Assignments (4)
CHANGE OF PATENTEE ADDRESS Recorded Feb 8, 2021
From: ADVERIO PHARMA GMBH
To: ADVERIO PHARMA GMBH
Reel/Frame 056907/0570 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2018
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 046790/0583 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2018
From: BAYER INTELLECTUAL PROPERTY GMBH
To: ADVERIO PHARMA GMBH
Reel/Frame 046790/0738 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2018
From: FEY, PETE
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 046469/0213 →